Manulife Extends Strategic Partnership with CUHK Medical Centre to Include Histotripsy in its Holistic "Medical Professional Support Service"
Histotripsy is an FDA-approved technology that offers liver cancer patients a non-invasive, painless, and highly effective treatment option HONG KONG, March 7, 2025 /PRNewswire/ -- Manulife announced today the extension of its strategic partnership...